In the field of medicine, long-term data have often been considered the gold standard of outcomes data. And while this holds true in cardiology as well, for the burgeoning practice of transcatheter aortic valve replacement, there have been signs that the release of contemporarily relevant long-term data may prove elusive for the foreseeable future.
During the past decade, the options for practitioners of transcatheter aortic valve replacement have expanded on a regular basis.
This wave of commercially available transcatheter valves has provided clinicians with more tools in their armamentarium, allowing them to individualize the treatment of aortic stenosis to the specific patient.